The Next Frontier of Healthtech Innovation

Summary

Healthtech, encompassing everything from digital therapeutics to artificial intelligence (AI)-driven diagnostics, is reshaping healthcare and becoming a crucial element of healthcare delivery by enhancing accessibility, convenience, and personalization of services. As healthcare costs continue to rise, driven by factors such as aging populations, prevalence of chronic diseases, and increasing costs of treatments, healthtech offers ways to make healthcare more affordable and sustainable.

Healthtech provides an opportunity to make healthcare more patient-centric—a model believed to be a promising way to decrease costs while at the same time improving health-related quality of life. By focusing on individual patient needs through personalized care plans, healthtech empowers patients to take more active role in managing their health, ultimately driving down healthcare costs.

Key Findings of the report include -

  • South Korea’s drug development is growing, focusing on early R&D and CGTs.
  • South Korea is advancing therapies like ADCs, mRNA, and CAR-T.
  • The rise in drug approvals in recent years highlights South Korea’s strong regulatory support.
  • South Korea’s pharma deals have slowed in recent years, but strategic alliances remain key.
  • Phase I clinical trials have become the focus in South Korea, representing the largest category.
Scope
  • GlobalData’s Healthtech report provides in-house analyst expertise on the impact of the five broad innovation categories (personalized and precision medicine, virtual care (telemedicine), artificial intelligence, robotics and virtual/augmented reality) and highlights big players in key healthcare technology categories.
  • Components of the report include -
      Key Players — identify the big players in key healthcare innovation categories that may be disrupted over the next two years.
    • Trends in Healthtech — identify key trends expected to occur in the global healthcare sector over the next two years.
    • Industry Analysis — identify the impact of innovations across major markets.
    • Value Chain - identify the five primary ways in which technology is changing the delivery of healthcare: prevention, diagnosis, treatment, monitoring, and recording.
    Reasons to Buy
    • Develop and design your corporate strategies through an in-house expert analysis of the five broad innovation categories expected to impact the healthcare industry.
    • Develop business strategies by understanding the primary ways in which technology is changing the delivery of healthcare.
    • Stay up to date on the industry’s major players in healthtech and where they sit in the value chain.
    • Identify emerging industry trends in in the global healthcare sector to gain a competitive advantage.


    Executive Summary
    Players
    Innovation Briefing
    The impact of healthtech innovations on the value chain
    Prevention
    Diagnosis
    Treatment
    Monitoring
    Patient engagement
    Trends
    Healthcare trends
    Technology trends
    Macroeconomic trends
    Regulatory trends
    Industry Analysis
    Use Cases of Healthtech
    Versius surgical system: advancing precision and innovation in robotic surgery
    In clinical trials, the role of telemedicine surged during COVID-19 and still remains prominent
    Empowered patients are contributing towards increased use of healthtech
    AI use in clinical practice – physicians’ perspective
    Timeline
    Signals
    M&A trends
    Venture financing trends
    Strategic partnership trends
    Hiring trends
    Social media trends
    Value Chain
    Companies
    Public companies
    Private companies
    Sector Scorecards
    Pharmaceutical sector scorecards
    Who’s who
    Thematic screen for drug development
    Thematic screen for clinical trials
    Thematic screen for drug manufacturing
    Valuation screen
    Risk screen
    Abbreviations
    Further Reading
    GlobalData reports
    Our Thematic Research Methodology
    About GlobalData
    Contact Us
    List of Tables
    Table 1: Healthcare trends
    Table 2: Technology trends
    Table 3: Macroeconomic trends
    Table 4: Regulatory trends
    Table 5: The key M&A transactions associated with the artificial intelligence theme since January 2024
    Table 6: The key M&A transactions associated with the personalized and precision medicine theme since January 2024
    Table 7: The key M&A transactions associated with the virtual care theme since January 2024
    Table 8: The key M&A transactions associated with the VR/AR theme since January 2024
    Table 9: The key M&A transactions associated with the robotics theme since January 2024
    Table 10: Key venture financing deals associated with the artificial intelligence theme
    Table 11: The key venture financing deals associated with the personalized and precision medicine theme since January 2024
    Table 12: The key venture financing deals associated with the virtual care theme since January 2024
    Table 13: The key venture financing deals associated with the VR/AR theme since January 2024
    Table 14: The key venture financing deals associated with the robotics theme since January 2024
    Table 15: The key strategic partnerships associated with the artificial intelligence theme since January 2024
    Table 16: The key strategic partnerships associated with the personalized and precision medicine theme since January 2024
    Table 17: The Key strategic partnerships associated with the virtual care theme since January 2024
    Table 18: The key strategic partnership associated with the robotics theme since January 2024
    Table 19: Public companies
    Table 20: Private companies
    Table 21: Abbreviations
    Table 22: GlobalData reports
    List of Figures
    Figure 1: Trends in global health and healthcare
    Figure 2: Players in the healthtech theme
    Figure 3: Integration of healthtech enhances the healthcare value chain
    Figure 4: Current health expenditure in current PPP per capita in $ (Canada, Mexico, US, France, Germany, Italy, Spain, UK, Australia, Japan, and South Korea)
    Figure 5: The growth of the AI healthcare market between 2024–28 (Canada, Mexico, US, France, Germany, Italy, Spain, UK, Australia, Japan, and South Korea combined)
    Figure 6: Patients’ view on AI use in healthcare (Patients’ agreement level that using AI in healthcare could improve patient care)
    Figure 7: Telemedicine use in clinical trials
    Figure 8: HCPs’ views on virtual care role on patient empowerment
    Figure 9: Trends influencing patient empowerment
    Figure 10: Physician comfort level with using AI
    Figure 11: The healthtech story
    Figure 12: Healthtech M&A deals
    Figure 13: Healthtech venture financing trends
    Figure 14: Healthtech strategic partnership trends
    Figure 15: Healthtech hiring trends
    Figure 16: Healthtech social media trends
    Figure 17: The personalized and precision medicine value chain
    Figure 18: The telemedicine value chain
    Figure 19: The artificial intelligence value chain
    Figure 20: Robotics value chain
    Figure 21: The virtual reality value chain
    Figure 22: The augmented reality value chain
    Figure 23: Who does what in the pharmaceutical sector?
    Figure 24: Thematic screen for drug development
    Figure 25: Thematic screen for clinical trials
    Figure 26: Thematic screen for drug manufacturing
    Figure 27: Valuation screen
    Figure 28: Risk screen
    Figure 29: Our five-step approach for generating a sector scorecard

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings